Recent Transactions

18-Mar-21
$750 million
Canada flag
Target: 

Canopy Growth Corporation

United States flag
Acquiror: 
King Street Capital Management, L.P.

Advised Canopy Growth, a leading diversified cannabis company, on its US$750 million term loan financing with King Street Capital Management, L.P.

01-Feb-21
$292 million
Canada flag
Target: 

Sunwing Airlines and Sunwing Vacations

Canada flag
Acquiror: 
Canada Enterprise Emergency Funding Corp.

Advised Sunwing, a leading Canadian travel company and leisure airline, on its C$375mm financing under the Large Employer Emergency Financing Facility (LEEFF) program administered by the Canada Enterprise Emergency Funding Corp. and overseen by the Government of Canada

24-Nov-20
$1.5 billion
Canada flag
Target: 

Cirque du Soleil

U.S.A., Canada flags
Acquiror: 
Ad Hoc Group of Lenders

Advised the Company on its CCAA and Ch.15 proceedings and $1.5bn sale through a Sale and Investment Solicitation Process (SISP) 

27-Nov-19
$320 million
United States flag
Target: 

David’s Bridal Inc.

flag not available
Acquiror: 
N/A

Advised David’s Bridal, a leading bridal gown and special occasion dress retailer, on its out-of-court recapitalization

18-Nov-18
$876 million
United States flag
Target: 

David's Bridal

flag not available
Acquiror: 
N/A

Advised the Ad Hoc Group of the company's $481mm term loan with respect to the company's prepackaged Chapter 11 restructuring

02-May-18
$3.7 billion
Canada flag
Target: 

Concordia International Corp.

flag not available

Advised an Ad Hoc Group of Cross-over Debtholders on Concordia International’s cross-border Canadian restructuring and recapitalization, including a US$586.5mm common equity private placement, the equitization of ~US$1.7bn of unsecured debt and the partial paydown and exchange of ~US$2.2bn of secured debt

04-Oct-16
$223 million
U.S.A., U.K. flags
Target: 

US rights to Toprol-XL (AstraZeneca)

Canada flag
Acquiror: 
Aralez Pharmaceuticals Inc.

Advised Aralez Pharmaceuticals Inc., a global specialty pharmaceutical company in connection with the financing of its acquisition of the US rights to cardiovascular drug Toprol-XL (metoprolol succinate) and its Authorized Generic from AstraZeneca.

30-Jun-10
$820 million
U.S.A., Canada flags
Target: 

Trident Resources Corporation

Advised Chilton Investment Company on Trident’s financial restructuring and emergence from CCAA / Chapter 11 bankruptcy protection including the negotiation of a new equity investment

29-Jul-09
$138 million
Canada flag
Target: 

Groupe Aeroplan Inc.

Advised Groupe Aeroplan on its C$150MM participation in a C$600MM credit facility for Air Canada

21-Jul-09
$2.8 billion
U.S.A., Canada flags
Target: 

Quebecor World Inc

Acted as financial advisor to Quebecor World on its CCAA / Chapter 11 restructuring

15-Oct-02
$3.2 billion
Canada flag
Target: 

AT&T Canada

Advised AT&T Canada on a stand-alone financial restructuring

16-Jul-01
$982 million
United States flag
Target: 

Sterling Chemicals

Advised Sterling Chemicals in connection with its Chapter 11 proceedings

show all